Trilaciclib (T) decreases myelosuppression in extensive-stage small cell lung cancer (ES-SCLC) patients receiving first-line chemotherapy plus atezolizumab

D Daniel, V Kuchava, I Bondarenko, O Ivashchuk, D Spigel, A Dasgupta, S Reddy, T Melkadze, J Jaal, I Kudaba, L Hart, A Matitashvili, KD Koynov, Z Yang, SG Wolfe, R Malik, SR Morris, JM Antal, J Goldschmidt

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Pages (from-to)713
Number of pages1
JournalAnnals of Oncology
Issue numberSuppl.5
Publication statusPublished - Oct 2019
Externally publishedYes
EventEuropean Society of Medical Oncology (ESMO) Congress - Barcelona, Spain
Duration: 27 Sept 20191 Oct 2019
Conference number: 44

Field of Science*

  • 3.2 Clinical medicine

Publication Type*

  • 3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

Cite this